DK0854707T3 - Faste lægemiddelformer, som opnåes ved ekstrusion af en isomalt indeholdende smeltet masse af en polymer og et biologisk virksomt stof - Google Patents

Faste lægemiddelformer, som opnåes ved ekstrusion af en isomalt indeholdende smeltet masse af en polymer og et biologisk virksomt stof

Info

Publication number
DK0854707T3
DK0854707T3 DK96934494T DK96934494T DK0854707T3 DK 0854707 T3 DK0854707 T3 DK 0854707T3 DK 96934494 T DK96934494 T DK 96934494T DK 96934494 T DK96934494 T DK 96934494T DK 0854707 T3 DK0854707 T3 DK 0854707T3
Authority
DK
Denmark
Prior art keywords
extrusion
isomal
polymer
active substance
biologically active
Prior art date
Application number
DK96934494T
Other languages
English (en)
Inventor
Juergen Zeidler
Joerg Rosenberg
Joerg Neumann
Joerg Breitenbach
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK0854707T3 publication Critical patent/DK0854707T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK96934494T 1995-09-29 1996-09-30 Faste lægemiddelformer, som opnåes ved ekstrusion af en isomalt indeholdende smeltet masse af en polymer og et biologisk virksomt stof DK0854707T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19536394A DE19536394A1 (de) 1995-09-29 1995-09-29 Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze
PCT/EP1996/004262 WO1997012603A1 (de) 1995-09-29 1996-09-30 Feste arzneiformen, erhältlich durch extrusion einer isomalt enthaltenden polymer-wirkstoff-schmelze

Publications (1)

Publication Number Publication Date
DK0854707T3 true DK0854707T3 (da) 2002-12-16

Family

ID=7773633

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96934494T DK0854707T3 (da) 1995-09-29 1996-09-30 Faste lægemiddelformer, som opnåes ved ekstrusion af en isomalt indeholdende smeltet masse af en polymer og et biologisk virksomt stof

Country Status (22)

Country Link
US (1) US6187342B1 (da)
EP (1) EP0854707B1 (da)
JP (1) JP4041163B2 (da)
KR (1) KR19990063853A (da)
CN (1) CN1200694C (da)
AT (1) ATE228355T1 (da)
AU (1) AU7282896A (da)
BG (1) BG102346A (da)
BR (1) BR9610799A (da)
CA (1) CA2230950C (da)
CZ (1) CZ95998A3 (da)
DE (2) DE19536394A1 (da)
DK (1) DK0854707T3 (da)
ES (1) ES2187678T3 (da)
HU (1) HUP9903384A3 (da)
IL (1) IL123250A (da)
MX (1) MX9801988A (da)
NO (1) NO981394L (da)
RU (1) RU2197228C2 (da)
TW (1) TW438599B (da)
WO (1) WO1997012603A1 (da)
ZA (1) ZA968130B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19809242A1 (de) * 1998-03-05 1999-09-09 Basf Ag Verfahren zur Herstellung von festen, sphärischen Formkörpern, enthaltend pharmazeutische Wirkstoffe in einer Bindemittelmatrix
US6465009B1 (en) 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
EP1175205B1 (en) * 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) * 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20070141107A1 (en) * 2000-03-15 2007-06-21 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
WO2002064093A2 (en) * 2001-02-15 2002-08-22 King Pharmaceuticals, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
PL364621A1 (en) * 2001-03-26 2004-12-13 Smithkline Beecham Corporation Nicotine-containing oral dosage form
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030181524A1 (en) * 2001-10-29 2003-09-25 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
KR100514590B1 (ko) * 2001-12-18 2005-09-14 주식회사 대웅 프라바스타틴나트륨 및 안정화제로서의 코폴리비돈을함유하는 약제 조성물
US20040101543A1 (en) * 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form
WO2004054568A1 (en) * 2002-12-17 2004-07-01 Abbott Gmbh & Co. Kg Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
CA2509958A1 (en) * 2003-02-03 2004-08-19 Novartis Ag Pharmaceutical formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
GB2418854B (en) * 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
EP2140861A1 (en) * 2008-06-30 2010-01-06 Abbott GmbH & Co. KG Pharmaceutical dosage form comprising polymeric carrier composition
ES2511145T3 (es) * 2010-10-14 2014-10-22 Abbott Gmbh & Co. Kg Formulación de dispersión sólida de curcuminoides
BR112013023879B1 (pt) 2011-03-21 2022-08-30 Boehringer Ingelheim International Gmbh Preparações sólidas que contém ambroxol, seu método de preparação, forma de dosagem farmacêutica e seus usos
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
US20190217531A1 (en) * 2016-04-06 2019-07-18 Astellas Pharma Inc. Fast-eluting three-dimensionally molded object, filament for fast-eluting three-dimensionally molded object, and material for fast-eluting three-dimensionally molded object

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3826946C1 (da) 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
DE69527711T2 (de) 1994-06-14 2002-12-05 Biovail Technologies Ltd., Chantilly Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt

Also Published As

Publication number Publication date
ATE228355T1 (de) 2002-12-15
CN1200694C (zh) 2005-05-11
CN1198094A (zh) 1998-11-04
JP4041163B2 (ja) 2008-01-30
BG102346A (bg) 1998-10-30
IL123250A (en) 2000-08-31
ES2187678T3 (es) 2003-06-16
ZA968130B (en) 1998-03-27
CA2230950A1 (en) 1997-04-10
WO1997012603A1 (de) 1997-04-10
EP0854707B1 (de) 2002-11-27
CZ95998A3 (cs) 1998-08-12
RU2197228C2 (ru) 2003-01-27
TW438599B (en) 2001-06-07
NO981394D0 (no) 1998-03-27
HUP9903384A2 (hu) 2000-10-28
NO981394L (no) 1998-03-27
JPH11512729A (ja) 1999-11-02
HUP9903384A3 (en) 2001-04-28
DE19536394A1 (de) 1997-04-03
EP0854707A1 (de) 1998-07-29
MX9801988A (es) 1998-08-30
DE59609923D1 (de) 2003-01-09
CA2230950C (en) 2007-12-04
BR9610799A (pt) 1999-07-13
KR19990063853A (ko) 1999-07-26
AU7282896A (en) 1997-04-28
IL123250A0 (en) 1998-09-24
US6187342B1 (en) 2001-02-13

Similar Documents

Publication Publication Date Title
DK0854707T3 (da) Faste lægemiddelformer, som opnåes ved ekstrusion af en isomalt indeholdende smeltet masse af en polymer og et biologisk virksomt stof
NO973730L (no) Faste virkestofftilberedninger
BRPI9509286B8 (pt) microcápsulas medicamentosas e/ou nutricionais para administração per si.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
BR9811793A (pt) MacrÈmeros biodegradáveis para a liberação controlada de substâncias biologicamente ativas.
BR9914251A (pt) Formulações orais de liberação sustentada
EP1158021A4 (en) MICROGELS AND EXTERNAL APPLICATION PREPARATIONS CONTAINING THESE MICROGELS
MD1233C2 (ro) Derivaţi de eritromicină, procedeu de preparare a lor şi compoziţie farmaceutică pe baza acestora
HUP9903734A2 (hu) Szabályozott felszabadulású, orális gyógyszerkészítmények és eljárás ezek előállítására
CA2420874A1 (en) Active ingredient combinations with insecticidal and acaricidal properties
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
EP0950402A3 (en) Chewable pharmaceutical composition with gelatin matrix
AU7915898A (en) Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
CY1105388T1 (el) Μορφη δοσολογιας πepιλαμβανουσα θepαπευτικο σκευασμα
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
CA2385890A1 (en) Controlled release compositions comprising nimesulide
IL117226A (en) Compositions for controlling parasites and process for preparation thereof
WO2001076369A3 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
ID22763A (id) Komposisi penstabil tibolon
WO2001078682A3 (en) Sustained release drug compositions
HUP9802716A2 (hu) Fájdalomcsillapító gyógyszerkombináció
HRP20000704B1 (en) Controlled release peroral compositions of levosimendan
WO2000064427A3 (en) Lamivudine containing pharmaceutical formulation
RU95102322A (ru) Сульфонамидодиоксепаны, способы их получения, фармацевтические препараты на их основе